Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Melinta Therapeutics, Inc.

http://www.melinta.com/

Latest From Melinta Therapeutics, Inc.

Deal Watch: Graphite Exits Via Reverse Merger With Presbyopia Specialist LENZ

Plus deals involving Abliva/Owl, Selecta/Cartesian, Novo Nordisk/Genevant, AbbVie/Aldeyra and more.

Deal Watch Business Strategies

J&J Saves Cidara’s Flu ‘Drug Cocktail’ From Pipeline Purge

Cidara Therapeutics has been given a lifeline after Johnson & Johnson’s opt-in on its universal flu prevention treatment – though the big pharma is expected to pass it onto a third party.

Deals Infectious Diseases

Several Options Remain For Cidara’s Flu Candidate After J&J Halts Development

Clinical work on the US biotech’s drug-Fc conjugate, CD388, has been stopped by partner Janssen amid a broader company shift, but there are several paths forward for Cidara after the asset showed early promise in a Phase IIa trial.

Companies Deals

Industry Refuses To Let Congress Forget PASTEUR Act

Melinta CEO and a representative of the Infectious Diseases Society of America call on a Senate HELP subcommittee to push for passage of PASTEUR Act. Introduced in the Senate and House for the third time this year, the measure would establish a subscription model to pay drug developers upfront for certain antimicrobials.

Legislation Infectious Diseases
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • Other Names / Subsidiaries
    • Rib-X Pharmaceuticals, Inc.
    • Cempra, Inc. (Cempra Pharmaceuticals, Inc.)
UsernamePublicRestriction

Register